Research and Development

Clinical Trials Investment Trends Innovation Investment AI in Healthcare Vaccines Gene Therapy Obesity Treatments Clinical Programs Market Dynamics Healthcare Companies Alzheimer's Disease Therapies Innovative Therapies Product Commercialization Pricing Strategies Immunology Oncology Treatments Chronic Diseases IL-2 Fusion Proteins Joint Ventures Product Pipeline

3 ARTICLES

last wk.

Scilex Signs Binding Term Sheet for $100 Million Equity Investment From iHolding

About 6.7 million new shares are priced at $15 each to finance product development, commercialization and acquisitions pending regulatory and corporate approvals.

9 ARTICLES

4w ago

AbbVie Strikes Trump Drug-Pricing Deal, Pledges $100 Billion, Wins 3-Year Tariff Reprieve

Research and Development

Scilex Signs Binding Term Sheet for $100 Million Equity Investment From iHolding

U.S. Opens Section 301 Probe Into Germany's Drug Pricing

HCW Biologics Posts Surprise Q1 Profit on Trimmune Deal as Listing Risk Lingers

Pfizer Beats Q1 Forecasts as Newer Drugs Offset COVID Slide

AbbVie to Build $1.4 Billion Injectable-Medicines Campus in Durham, N.C.

AbbVie to Invest $380 Million in Two North Chicago API Plants

Vertex Heads Into Feb. 12 Earnings With Cautious Market After Mixed Year

AbbVie Strikes Trump Drug-Pricing Deal, Pledges $100 Billion, Wins 3-Year Tariff Reprieve